Who owns VIRPAX PHARMACEUTICALS INC?
- CUSIP Number: 928251107
Tip: Access positions for across all investors
Analyze quarterly positions in Virpax Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Virpax Pharmaceuticals stock
Who bought or sold VIRPAX PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Parallel Advisors | 1.00 | $4.000000 | -93% | Mar 2024 |
|
Who sold out of Virpax Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Pnc Financial Services | Dec 2023 | 101k | $32k |
| Vanguard Group | Dec 2023 | 66k | $21k |
| Geode Capital Management | Sep 2023 | 64k | $51k |
| Sheets Smith Wealth Management | Dec 2023 | 50k | $16k |
| Northern Trust | Sep 2023 | 15k | $12k |
| Two Sigma Securities | Dec 2023 | 12k | $3.7k |
| UBS Group | Dec 2023 | 6.6k | $2.1k |
| Tower Research Capital | Sep 2023 | 6.2k | $5.0k |
| Jpmorgan Chase & Co | Dec 2023 | 4.4k | $1.4k |
| Advisor Group Holdings | Dec 2023 | 2.4k | $768.000000 |
| Signature Resources Capital Management | Dec 2023 | 500.00 | $160.000000 |
| BlackRock | Sep 2023 | 464.00 | $371.014400 |
| Morgan Stanley | Sep 2023 | 150.00 | $120.000000 |
| Wells Fargo & Company | Dec 2023 | 67.00 | $20.997800 |